Virbac SA (VRBCF)

USD 339.23

(0.0%)

Market Cap (In USD)

2.81 Billion

Revenue (In USD)

1.24 Billion

Net Income (In USD)

121.29 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
288.0-385.6
PE
-
EPS
-
Beta Value
0.966
ISIN
FR0000031577
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Habib Ramdani
Employee Count
-
Website
https://corporate.virbac.com
Ipo Date
2013-04-17
Details
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.